A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants
Status:
Recruiting
Trial end date:
2021-12-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of loperamide on QT/ QT interval corrected
for heart rate (QTc) intervals and electrocardiogram (ECG) morphology at therapeutic and
supratherapeutic exposures in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC
Treatments:
Antidiarrheals Loperamide Moxifloxacin Norgestimate, ethinyl estradiol drug combination